1. Home
  2. NC vs LXEO Comparison

NC vs LXEO Comparison

Compare NC & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NACCO Industries Inc.

NC

NACCO Industries Inc.

HOLD

Current Price

$47.40

Market Cap

352.0M

Sector

Energy

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$4.13

Market Cap

396.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NC
LXEO
Founded
1913
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
352.0M
396.5M
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
NC
LXEO
Price
$47.40
$4.13
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$18.44
AVG Volume (30 Days)
8.9K
937.9K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
2.07%
N/A
EPS Growth
N/A
39.81
EPS
1.17
N/A
Revenue
$104,778,000.00
$654,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$40.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.43
$4.03
52 Week High
$59.42
$10.99

Technical Indicators

Market Signals
Indicator
NC
LXEO
Relative Strength Index (RSI) 40.07 38.16
Support Level $44.66 $4.03
Resistance Level $50.51 $5.36
Average True Range (ATR) 1.22 0.29
MACD 0.06 -0.04
Stochastic Oscillator 8.38 7.72

Price Performance

Historical Comparison
NC
LXEO

About NC NACCO Industries Inc.

NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments: Utility Coal Mining, Contract Mining, and Minerals and Royalties. The Utility Coal Mining segment, operated by North American Coal, manages surface coal mines that are exclusive, long-term fuel providers for power generation companies. The Contract Mining segment, operated by North American Mining, is a provider of a broad range of specialized, long-term contract mining services. The Minerals and Royalties segment, which includes the Catapult Mineral Partners (Catapult) business, acquires and promotes the development of mineral and royalty interests and other related investments.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: